Mobile

A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lym...

Update Il y a 4 ans
Reference: EUCTR2004-000440-24

A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lymphocytic Leukemia (CLL)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine the overall response rate (Complete Response and Partial Response) of patients receiving chlorambucil with or without SDX-101 for the treatment of CLL.

Inclusion criteria

  • Chronic lymphocytic leukemia (CLL)

Links